United Therapeutics (NASDAQ:UTHR) Price Target Cut to $385.00 by Analysts at UBS Group

Oregon Public Employees Retirement Fund Decreases Stake in United Therapeutics Corporation (NASDAQ:UTHR)

Oregon Public Employees Retirement Fund cut its stake in shares of United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 0.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,060 shares of the biotechnology company’s stock after selling 48 shares during the […]

UBS Group Lowers Halliburton (NYSE:HAL) Price Target to $21.00

Halliburton (NYSE:HAL – Get Free Report) had its target price lowered by stock analysts at UBS Group from $22.00 to $21.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the oilfield services company’s stock. UBS Group’s price target points to a potential downside of 2.28% […]

United Therapeutics (NASDAQ:UTHR) Price Target Cut to $385.00 by Analysts at UBS Group

United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective reduced by UBS Group from $410.00 to $385.00 in a research note issued to investors on Monday,Benzinga reports. UBS Group currently has a buy rating on the biotechnology company’s stock. A number of other brokerages also recently issued reports on UTHR. JPMorgan Chase & Co. […]

Summit Therapeutics (NASDAQ:SMMT) Coverage Initiated at UBS Group

UBS Group started coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Get Free Report) in a report released on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $30.00 price target on the stock. UBS Group’s price target would indicate a potential upside of 32.63% from the company’s current price. A number […]